AntiCancer, CRI Settle Cancer Tracker Patent Suits
AntiCancer Inc. and Cambridge Research & Instrumentation Inc. have resolved two suits over CRI's alleged infringement of three patents covering technology that uses fluorescent proteins to track cancer growth and study...To view the full article, register now.
Already a subscriber? Click here to view full article